Back to Journals » OncoTargets and Therapy » Volume 17

Long Non-Coding RNA TRG-AS1 Promoted Proliferation and Invasion of Lung Cancer Cells Through the miR-224-5p/SMAD4 Axis [Retraction]

Authors Zhang M, Zhu W, Haeryfar M, Jiang S, Jiang X, Chen W, Li J

Received 16 April 2024

Accepted for publication 16 April 2024

Published 18 April 2024 Volume 2024:17 Pages 361—362

DOI https://doi.org/10.2147/OTT.S474055



Zhang M, Zhu W, Haeryfar M, et al. Onco Targets Ther. 2020;14:4415–4426.

We, the Editor and Publisher of the journal OncoTargets and Therapy, have retracted the following article.

Following publication of the article, concerns were raised about the duplication of images from Figures 2 and 4 with images from other unrelated articles. Specifically,

  • Images for Figure 2D have been duplicated with images for Figure 2D from Zheng S, Li M, Miao K, Xu H. SNHG1 contributes to proliferation and invasion by regulating miR-382 in breast cancer. Cancer Manag Res. 2019;11:5589-5598. https://doi.org/10.2147/CMAR.S198624.
  • Images for Figure 2F have been duplicated with images for Figure 2e from Wang X, Su Y, Yin C. Long non-coding RNA (lncRNA) five prime to Xist (FTX) promotes retinoblastoma progression by regulating the microRNA-320a/with-no-lysine kinases 1 (WNK1) axis. Bioengineered. 2021;12(2):11622–11633. https://doi.org/10.1080/21655979.2021.1994718.
  • Images for Figure 4D have been duplicated with images for Figure 3A and7A from Chen X, Wu G, Qing J, Li C, Chen X, Shen J. LINC00240 knockdown inhibits nasopharyngeal carcinoma progress by targeting miR-26a-5p. J Clin Lab Anal. 2022;36:e24424. https://doi.org/10.1002/jcla.24424 and Figure 8A from Zhu Y, Li J, Liu H, et al. Circular RNA, hsa_circRNA_102049, promotes colorectal cancer cell migration and invasion via binding and suppressing miRNA‑455‑3p. Experimental and Therapeutic Medicine. 2022;23:244. https://doi.org/10.3892/etm.2022.11169.

The authors responded to our queries but were unable to provide a satisfactory explanation for the duplicated images or provide satisfactory data for the study. As verifying the validity of published work is core to the integrity of the scholarly record, we are therefore retracting the article and the authors were notified of this.

We have been informed in our decision-making by our editorial policies and COPE guidelines.

The retracted article will remain online to maintain the scholarly record, but it will be digitally watermarked on each page as “Retracted”.


This retraction relates to this paper


Creative Commons License © 2024 The Author(s). This work is published and licensed by Dove Medical Press Limited. The full terms of this license are available at https://www.dovepress.com/terms.php and incorporate the Creative Commons Attribution - Non Commercial (unported, v3.0) License. By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. For permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms.